Atlas Trials

Docetaxel, Irinotecan, and Carboplatin in Extensive Stage Non-Small Cell Lung Cancer

Clinical trial NCT00264134 · TERMINATED

Trial details

NCT number
NCT00264134
Sponsor
Kentuckiana Cancer Institute
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung CancerExtensive Stage Unresectable
Start date
2003-06-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.